General Information of Drug (ID:
DR3190) |
Drug Name |
Flupirtine
|
Synonyms |
Flupirtine; 56995-20-1; Flupirtine [INN:BAN]; Flupirtinum [INN-Latin]; Flupirtino [INN-Spanish]; UNII-MOH3ET196H; C15H17FN4O2; EINECS 260-503-8; MOH3ET196H; JUUFBMODXQKSTD-UHFFFAOYSA-N; ethyl N-[2-amino-6-[(4-fluorophenyl)methylamino]pyridin-3-yl]carbamate; D 9998; flupirtin maleate; ethyl 2-amino-6-(4-fluorobenzylamino)pyridin-3-ylcarbamate; Flupirtinum; Flupirtino; MLS002153180; Carbamic acid, (2-amino-6-(((4-fluorophenyl)methyl)amino)-3-pyridinyl)-, ethyl ester; NCGC00015451-03; SMR001230672; Flupirtin; Carbamic acid, [2-ami
|
Indication |
Cancer related pain
[ICD11: MG30]
|
Phase 2
|
[1]
|
Fibromyalgia
[ICD11:
ICD11: MG30]
|
Phase 2
|
[2]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
304.32 |
Topological Polar Surface Area |
89.3 |
Heavy Atom Count |
22 |
Rotatable Bond Count |
6 |
Hydrogen Bond Donor Count |
3 |
Hydrogen Bond Acceptor Count |
6 |
Cross-matching ID |
- PubChem CID
- 53276
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D0SD9V
- Formula
- C15H17FN4O2
- Canonical SMILES
- CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N
- InChI
- InChI=1S/C15H17FN4O2/c1-2-22-15(21)19-12-7-8-13(20-14(12)17)18-9-10-3-5-11(16)6-4-10/h3-8H,2,9H2,1H3,(H,19,21)(H3,17,18,20)
- InChIKey
- JUUFBMODXQKSTD-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.